RARA CRAFT DATABASE for FDA Medical Devices
510(k)K253576

FDA DEVICE FACTS

CorVista System® with PCWP Add-On

Analytics For Life, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

AI/ML
DECISION DATEJuly 26, 2026PRODUCT CODEDQK

Indications for use

The CorVista System with PCWP Add-on analyzes sensor-acquired physiological signals of patients presenting with cardiovascular symptoms (such as chest pain, dyspnea, fatigue) with no history of elevated PCWP or prior right heart catheterization. It provides a binary output and indicates the likelihood of elevated PCWP defined as >18 mmHg as measured by right heart catheterization (RHC). The analysis is presented for interpretation by healthcare providers in conjunction with their clinical judgment, the patient's signs, symptoms, and clinical history as an aid in diagnosis. Indications for Use Comparison The proposed Indications for Use for the CorVista System with PCWP Add-On and the Indications for Use of the proposed predicate device (K233666) are different. The CorVista System with PH Add-On displays a different disease state likelihood than the proposed predicate device (K233666). The CorVista System with PCWP Add-On displays the patient’s likelihood of elevated PCWP, while the proposed predicate device displays the patient's likelihood of elevated mean Pulmonary Arterial Pressure (mPAP). The safety and effectiveness of the CorVista System with these differences has been confirmed through clinical testing. Both the CorVista System with PCWP Add-On and the proposed predicate device (K233666) have identical intended use as CorVista® System Traditional 510(k) Request Analytics for Life, Inc. Confidentiality both devices are intended to non-invasively analyze physiological signals using machine learning techniques to output the likelihood of a cardiovascular disease or condition.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 1, 2026